Shape information from glucose curves: Functional data analysis compared with traditional summary measures

BMC Medical Research Methodology

Volumn 13, Issue 1, 2013, Pages

  Frøslie, Kathrine Frey ^a,b   Røislien, Jo ^a   Qvigstad, Elisabeth ^b   Godang, Kristin ^b   Bollerslev, Jens ^a,b   Voldner, Nanna ^b   Henriksen, Tore ^a,b   Veierød, Marit B ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Area under the curve; Curve shape; Functional data analysis; Functional principal component analysis; Gestational diabetes; Glucose curve; Glucose oscillations; Glucose variability; Oral glucose tolerance test; Pregnancy

Indexed keywords

ARTICLE; COMPARATIVE STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; METABOLISM; PREGNANCY; PRINCIPAL COMPONENT ANALYSIS; TASK PERFORMANCE;

BLOOD GLUCOSE; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; PREGNANCY; PRINCIPAL COMPONENT ANALYSIS; TIME AND MOTION STUDIES;

MLCS; MLOWN;

EID: 84872274207     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-13-6     Document Type: Article

References (51)

1. Definition, diagnosis and classification of diabetes mellitus and its complications part 1: Diagnosis and classification of diabetes mellitus-Provisional report of a WHO consultation. Alberti KGMM, Zimmet PZ, Diabet Med 1998 15 539 553 10.1002/(SICI)1096-9136(199807)15:7<539::AID- DIA668>3.0.CO;2-S 9686693
2. World Health Organization, Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Report of a WHO/IDF consultation Geneva: World Health Organization 2006
3. Standards of Medical Care in Diabetes-2011. American Diabetes Association, Diabetes Care 2011 34 Suppl 1 11 S61 21193625
4. Hyperglycemia and adverse pregnancy outcomes. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA, HAPO Study Cooperative Research Group, N Engl J Med 2008 358 1991 2002 18463375
5. Carbohydrates. Levin RJ, Modern nutrition in health and disease Baltimore: Lippincott Williams & Wilkins, Shils ME, Olson JA, Shine M, Ross AC, 9 1999 49 65
6. Fiber and other dietary factors affecting nutrient absorption and metabolism. Jenkins DJA, Woelver TMS, Jenkins AL, Modern nutrition in health and disease Baltimore: Lippincott Williams & Wilkins, Shils ME, Olson JA, Shine M, Ross AC, 9 1999 679 698
7. MedlinePlus, Glucose tolerance test http://www.nlm.nih.gov/medlineplus/ ency/article/003466.htm
8. Norwegian Directorate of Health, National guidelines. Diabetes. Prevention, diagnostics and treatment. (In Norwegian.) http://helsedirektoratet. no/publikasjoner/nasjonale-faglige-retningslinjer - -diabetes-brukerversjon/ Publikasjoner/nasjonal-faglig-retningslinje - -diabetes-brukerversjon.pdf
9. Diabetes and cancer: a consensus report. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D, Diabetes Care 2010 33 1674 1685 10.2337/dc10-0666 20587728
10. Transition models for change-point estimation in logistic regression. Pastor-Barriuso R, Guallar E, Coresh J, Stat Med 2003 22 1141 1162 10.1002/sim.1045 12652559
11. Assessing 1-h plasma glucose and shape of the glucose curve during oral glucose tolerance test. Zhou WB, Gu YY, Li H, Luo M, Eur J Endocrinol 2006 155 191 197 10.1530/eje.1.02188 16793967
12. Assessing the shape of the glucose curve during an oral glucose tolerance test. Tschritter O, Fritsche A, Shirkavand F, Machicao F, Haring H, Stumvoll M, Diabetes Care 2003 26 1026 1033 Erratum 27:1855 10.2337/diacare.26.4.1026 12663568
13. Shape of glucose, insulin, C-peptide curves during a 3-h oral glucose tolerance test: any relationship with the degree of glucose tolerance? Tura A, Morbiducci U, Sbrignadello S, Winhofer Y, Pacini G, Kautzky-Willer A, Am J Physiol Regul Integr Comp Physiol 2011 300 941 R948 10.1152/ajpregu.00650.2010 21248305
14. Fitting and evaluating the glucose curve during a quasi continuous sampled oral glucose tolerance test. Trujillo-Arriaga HM, Roman-Ramos R, Comput Biol Med 2008 38 185 195 10.1016/j.compbiomed.2007.09.004 17991459
15. Longitudinal changes in the continuous glucose profile measured by the CGMS in healthy pregnant women and determination of cut-off values. Siegmund T, Rad NT, Ritterath C, Siebert G, Henrich W, Buhling KJ, Eur J Obstet Gynecol Reprod Biol 2008 139 46 52 10.1016/j.ejogrb.2007.12.006 18262325
16. Diurnal glycemic profile in obese and normal weight nondiabetic pregnant women. Yogev Y, Ben-Haroush A, Chen R, Rosenn B, Hod M, Langer O, Am J Obstet Gynecol 2004 191 949 953 10.1016/j.ajog.2004.06.059 15467570
17. Ramsay JO, Silverman BW, Functional data analysis New York: Springer 2 2005
18. Ramsay JO, Hooker G, Gray J, Functional data analysis with R and MATLAB New York: Springer 2009
19. Ramsay JO, Functional data analysis http://www.functionaldata.org
20. Functional principal component analysis of fMRI data. Viviani R, Gron G, Spitzer M, Hum Brain Mapp 2005 24 109 129 10.1002/hbm.20074 15468155
21. Functional data analysis applied to a randomized controlled clinical trial in hemodialysis patients describes the variability of patient responses in the control of renal anemia. West RM, Harris K, Gilthorpe MS, Tolman C, Will EJ, J Am Soc Nephrol 2007 18 2371 2376 10.1681/ASN.2006050436 17625113
22. Common functional principal components analysis: A new approach to analyzing human movement data. Coffey N, Harrison AJ, Donoghue OA, Hayes K, Hum Mov Sci 2011 30 1144 1166 10.1016/j.humov.2010.11.005 21543128
23. Functional data analysis for gait curves study in Parkinson's disease. Duhamel A, Devos P, Bourriez JL, Preda C, Defebvre L, Beuscart R, Stud Health Technol Inform 2006 124 569 574 17108578
24. Modifiable determinants of fetal macrosomia: role of lifestyle-related factors. Voldner N, Frøslie KF, Bo K, Haakstad L, Hoff C, Godang K, Bollerslev J, Henriksen T, Acta Obstet Gynecol Scand 2008 87 423 429 10.1080/00016340801989825 18382868
25. Voldner N, Modifiable determinants of newborn macrosomia and birth complications.PhD thesis. University of Oslo, Faculty of Medicine 2010
26. Correction of an unexpected increasing trend in glucose measurements during 7 years recruitment to a cohort study. Frøslie KF, Godang K, Bollerslev J, Henriksen T, Røislien J, Veierød MB, Qvigstad E, Clin Biochem 2011 44 1483 1486 10.1016/j.clinbiochem.2011.08.1150 21945023
27. Obesity: Preventing and managing the global epidemic. World Health Organization, Report of a WHO Consultation Geneva: World Health Organization WHO Technical Report Series. 2000
28. International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy. International Association of Diabetes and Pregnancy Study Groups, Diabetes Care 2010 33 676 682 20190296
29. Diagnosis and Classification of Diabetes Mellitus. American Diabetes Association, Diabetes Care 2012 35 Suppl 1 64 S71 22187472
30. Hosmer DW, Lemeshow S, Applied logistic regression New York: Wiley 2 2000
31. The R Foundation for Statistical Computing: R verison 2.13.0 (2011.04.13) http://www.r-project.org
32. Impact of recent antecedent hypoglycemia on hypoglycemic cognitive dysfunction in nondiabetic humans. Hvidberg A, Fanelli CG, Hershey T, Terkamp C, Craft S, Cryer PE, Diabetes 1996 45 1030 1036 10.2337/diabetes.45.8.1030 8690148
33. Dichotomizing continuous predictors in multiple regression: a bad idea. Royston P, Altman DG, Sauerbrei W, Stat Med 2006 25 127 141 10.1002/sim.2331 16217841
34. Abnormal Patterns of Insulin-Secretion in Non-Insulin-Dependent Diabetes-Mellitus. Polonsky KS, Given BD, Hirsch LJ, Tillil H, Shapiro ET, Beebe C, Frank BH, Galloway JA, Van Cauter E, N Eng J Med 1988 318 1231 1239 10.1056/NEJM198805123181903
35. Continuous glucose profiles in healthy subjects under everyday life conditions and after different meals. Freckmann G, Hagenlocher S, Baumstark A, Jendrike N, Gillen RC, Rössner K, Haug C, J Diabetes Sci Technol 2007 1 695 703 19885137
36. Day-to-day glucose variability during pregnancy in women with Type 1 diabetes mellitus: Glucose profiles measured with the Continuous Glucose Monitoring System. Kerssen A, de Valk HW, Visser GHA, BJOG 2004 111 919 924 10.1111/j.1471-0528.2004.00203.x 15327605
37. Diabetes Prevention Trial-Type 1 Study Group: Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes-The Diabetes Prevention Trial-Type 1. Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS, Diabetes Care 2007 30 38 42 10.2337/dc06-1615 17192330
38. Selective contribution of regional adiposity, skeletal muscle, and adipokines to glucose disposal in older adults. Ramachandran R, Gravenstein KS, Metter EJ, Egan JM, Ferrucci L, Chia CW, J Am Geriatr Soc 2012 60 707 712 10.1111/j.1532-5415.2011.03865.x 22417789
39. The clinical usefulness of glucose tolerance testing in gestational diabetes to predict early postpartum diabetes mellitus. Weijers RNM, Bekedam DJ, Goldschmidt HMJ, Smulders YM, Clin Chem Lab Med 2006 44 99 104 16375594
40. Use of oral glucose tolerance test in early pregnancy to predict late-onset gestational diabetes mellitus in high-risk women. Phaloprakarn C, Tangjitgamol S, J Obstet Gynaecol Res 2008 34 331 336 10.1111/j.1447-0756.2007. 00693.x 18686344
41. Early metabolic markers of islet allograft dysfunction. Baidal DA, Faradji RN, Messinger S, Froud T, Monroy K, Ricordi C, Alejandro R, Transplantation 2009 87 689 697 10.1097/TP.0b013e318195c249 19295313
42. Trends of earlier and later responses of C-peptide to oral glucose challenges with progression to type 1 diabetes in diabetes prevention trial-type 1 participants. Sosenko JM, Palmer JP, Rafkin LE, Krischer JP, Cuthbertson D, Greenbaum CJ, Eisenbarth G, Skyler JS, Diabetes Prevention Trial-Type 1 Study Group, Diabetes Care 2010 33 620 625 10.2337/dc09-1770 20032282
43. Influences of glucose loading and of injected insulin on hepatic glucose output. Steele R, Ann N Y Acad Sci 1959 82 420 430 13833973
44. Insulin deficiency and insulin resistance interaction in diabetes-estimation of their relative contribution by feedback analysis from basal plasma-insulin and glucose-concentrations. Turner RC, Holman RR, Matthews D, Hockaday TDR, Peto J, Metab Clin Experimental 1979 28 1086 1096 10.1016/0026-0495(79)90146-X
45. Physiologic evaluation of factors controlling glucose-tolerance in man-measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. Bergman RN, Phillips LS, Cobelli C, J Clin Invest 1981 68 1456 1467 10.1172/JCI110398 7033284
46. Do gene variants influencing adult adiposity affect birth weight? A population-based study of 24 loci in 4,744 Danish individuals. Andersson EA, Pilgaard K, Pisinger C, Harder MN, Grarup N, Færch K, Sandholt C, Poulsen P, Witte DR, Jørgensen T, Vaag A, Pedersen O, Hansen T, PLoS One 2010 5 14190 10.1371/journal.pone.0014190 21152014
47. The assessment of insulin resistance in man. Wallace TM, Matthews DR, Diabet Med 2002 19 527 534 10.1046/j.1464-5491.2002.00745.x 12099954
48. Counterpoint: The oral glucose tolerance test is superfluous. Davidson MB, Diabetes Care 2002 25 1883 1885 10.2337/diacare.25.10.1883 12351497
49. Glucose clamp technique-method for quantifying insulin-secretion and resistance. Defronzo RA, Tobin JD, Andres R, Am J Physiol 1979 237 214 E223 382871
50. Effect of postprandial modulation of glucose availability: short- and long-term analysis. Nazare JA, de Rougemont A, Normand S, Sauvinet V, Sothier M, Vinoy S, Désage M, Laville M, Br J Nutr 2010 103 1461 1470 10.1017/S0007114509993357 20030904
51. Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes? Faerch K, Borch-Johnsen K, Holst JJ, Vaag A, Diabetologia 2009 52 1714 1723 10.1007/s00125-009-1443-3 19590846